![Peter Huang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Huang
Direttore Tecnico/Scientifico/R&S presso ZAI LAB LIMITED
Provenienza dei contatti di primo grado di Peter Huang
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Biotechnology | 22 | |
Public Company | Biotechnology | 16 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Peter Huang tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Virginia | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
AURA BIOSCIENCES, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
BIOGEN INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Compliance Officer | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Harvard Law School | College/University | Graduate Degree Graduate Degree | |
Lilly Oncology
![]() Lilly Oncology Hospital/Nursing ManagementHealth Services Part of Eli Lilly & Co., Lilly Oncology is an American company dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. With over 50 years of experience, Lilly Oncology is committed to building on their heritage and improving the lives of all those affected by cancer worldwide. | Hospital/Nursing Management | Corporate Officer/Principal Corporate Officer/Principal | |
IDEAYA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Matrix Capital Management Co. LP
![]() Matrix Capital Management Co. LP Investment ManagersFinance Matrix Capital Management Co. LP (Matrix) is an independent, SEC-registered investment adviser and hedge fund manager headquartered in Waltham, Massachusetts. The firm was founded by David E. Goel and Paul J. Ferri in 1999. Matrix serves as the manager or management firm with discretionary investment authority to private pooled investment vehicles, the securities of which are offered to investors on a private placement basis. | Investment Managers | Chief Executive Officer Portfolio Manager-Equities | |
Lengo Therapeutics, Inc.
![]() Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
University of Illinois | College/University | Undergraduate Degree Graduate Degree | |
Fudan University | College/University | Corporate Officer/Principal Doctorate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Stanford University | College/University | Doctorate Degree Masters Business Admin | |
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Hutchison MediPharma Ltd.
![]() Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Hutchison MediPharma Ltd. discovers and develops innovative human therapeutics. Its products include savolitinib, fruqnitinib, sulfatinib, HMPL-523, epitinib, theliatinib, HMPL-453, HMPL-689 and HMPL-004. The company was founded by Ying Samantha Du in September 2002 and is headquartered in Shanghai, China. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Peking Union Medical College | College/University | Undergraduate Degree Doctorate Degree | |
Kalyra Pharmaceuticals, Inc.
![]() Kalyra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kalyra Pharmaceuticals, Inc. manufactures small molecule drugs. The company was founded by Brian T. Dorsey, Cam L. Garner and Kevin Bunker and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Harold C Simmons Comprehensive Cancer Center | Director/Board Member | ||
ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member | |
GentiBio, Inc.
![]() GentiBio, Inc. BiotechnologyHealth Technology GentiBio, Inc. engages in the development of engineered regulatory T cells (EngTregs) programmed to treat autoimmune, alloimmune, autoinflammatory, and allergic diseases. The company was founded by Adel Nada, David Rawlings, Jane H. Buckner, and Gideon Gross and is headquartered in Seattle, WA. | Biotechnology | Chairman | |
NEON THERAPEUTICS, INC. | Biotechnology | President | |
Texas Tech University | College/University | Undergraduate Degree | |
DEM BioPharma, Inc.
![]() DEM BioPharma, Inc. Pharmaceuticals: MajorHealth Technology DEM BioPharma, Inc. is an American company that pioneers the next generation of immunotherapeutics to eliminate tumors by targeting 'don't eat me' and 'eat me' signals on cancer cells, macrophages, and other myeloid effector cells. The company is based in Cambridge, MA. The proprietary CHOMP™ platform utilizes CRISPR-based functional genomic screens to discover and validate new signals that could enhance cancer cell elimination through increased phagocytosis. The company was founded by Longwood Fund and builds on groundbreaking functional genomics research and discoveries in macrophage biology from its scientific co-founders. Nenad Grmusa has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chairman | |
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Leerink Partners LLC
![]() Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Analyst-Equity | |
The Damon Runyon Cancer Research Foundation
![]() The Damon Runyon Cancer Research Foundation Miscellaneous Commercial ServicesCommercial Services The Damon Runyon Cancer Research Foundation supports cancer research through grants to scientists in fields including cellular biology, genetics, immunology, and virology. It was founded in 1946 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Director/Board Member | |
SYNTHORX, INC. | Biotechnology | Corporate Officer/Principal | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
CORVUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
AUDENTES THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Endeavor BioMedicines, Inc
![]() Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | President | |
BIOCOM
![]() BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Alkermes, Inc.
![]() Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member | |
IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
UBS AG (New York)
![]() UBS AG (New York) Investment ManagersFinance UBS AG's (NYSE: UBS) New York City-based wealth management arm is known as UBS Private Banking (US). The firm provides a range of customized wealth management products and services for private clients. | Investment Managers | Corporate Officer/Principal | |
H.I.G. BioHealth Partners LLC
![]() H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
CVS HEALTH CORPORATION | Drugstore Chains | Corporate Officer/Principal | |
Texas Southern University | College/University | Doctorate Degree | |
Tuck School of Business at Dartmouth | College/University | Masters Business Admin | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
TRILLIUM THERAPEUTICS | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 46 |
Cina | 4 |
Irlanda | 2 |
Canada | 2 |
Settori
Health Technology | 22 |
Consumer Services | 15 |
Commercial Services | 9 |
Finance | 5 |
Health Services | 2 |
Posizioni
Director/Board Member | 177 |
Corporate Officer/Principal | 77 |
Independent Dir/Board Member | 59 |
Undergraduate Degree | 31 |
Chairman | 29 |
Contatti più connessi
Insiders | |
---|---|
Lonnie Moulder | 31 |
John Diekman | 29 |
Wing Yu Leung | 27 |
Tony Sun | 20 |
Kai Xian Chen | 20 |
David Goel | 18 |
Scott Morrison | 16 |
Peter Wirth | 15 |
Melissa Epperly | 13 |
Kimberly Blackwell | 13 |
Enoch Kariuki | 13 |
William Lis | 12 |
Richard Gaynor | 11 |
David Johnson | 11 |
Karan Takhar | 11 |
- Borsa valori
- Insiders
- Peter Huang
- Connessioni Società